While Narayana Hrudayalaya's (NH) Q2FY18 revenue was up 15% YoY, EBITDA slip (8% YoY decline) can largely be attributed to (1) EBITDA loss of ~Rs 80 mn at its recently-commissioned children's hospital in Mumbai and (2) Price control on cardiac stents which impacted profitability by ~Rs 70 mn.